Microwave Ablation of Resectable Liver Tumors
Withdrawn before enrolling
Conditions studied: Hepatocellular Carcinoma, Liver Cancer
In brief
The purpose of this protocol is to pathologically evaluate the destruction by microwave ablation of primary and metastatic liver tumors. The primary aim is to measure tissue destruction with the MedWaves Microwave Ablation/ Coagulation Ablation System.
Key facts
- Study ID
- NCT00892255
- Run by
- St. Joseph Hospital of Orange
- People needed
- 0
- Starts
- 2009-04-01
- Expected to finish
- 2009-04-01
- Last updated by the study team
- 2021-04-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of primary or metastatic liver cancer for which surgery is planned
- All participants need to be fully able to give informed consent
You may not qualify if…
- Mental or legal incompetence
- Impaired decision-making capacity
- Pregnant women may not participate
Where it is running
- The Center for Cancer Prevention & Treatment at St. Joseph Hospital — Orange, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.